During the past decade, CHIREC conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHIREC" #1 sponsor was "Pfizer" with 2 trials, followed by "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 1 trials sponsored, "IO Biotech" with 1 trials sponsored, "KU Leuven" with 1 trials sponsored and "Maastricht University Medical Center" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHIREC" #1 collaborator was "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator, "Anticancerfund" with 1 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 1 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator and "Belgian Cancer Registry" with 1 trials as a collaborator. Other collaborators include 94 different institutions and companies that were collaborators in the rest 104 trials.

According to Clinical.Site data, the most researched conditions in "CHIREC" are "ARDS, Human" (1 trials), "Ankylosing Spondylitis" (1 trials), "COVID" (1 trials), "Cardiogenic Shock" (1 trials) and "Colon Cancer" (1 trials). Many other conditions were trialed in "CHIREC" in a lesser frequency.

Most popular intervention types in "CHIREC" are "Drug" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "etanercept" (2 trials), "5 FU" (1 trials), "Bevacizumab" (1 trials), "IO102-IO103" (1 trials) and "Irinotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHIREC" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CHIREC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CHIREC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHIREC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

CHIREC has several departments that took part in Clinical trials: "Chirec Cancer Institute" - 2 trials